Drug intelligence / Profile preview

Boneflex

Development stage
Unknown
Lead developer
Geneith Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Boneflex is a multi-ingredient nutritional supplement developed and marketed by Geneith Pharmaceuticals, a Nigerian pharmaceutical company. It is specifically formulated to support joint health and manage symptoms associated with degenerative and inflammatory joint conditions, such as osteoarthritis and rheumatoid arthritis. The standard Boneflex formulation contains glucosamine, chondroitin, and omega-3 fish oil, which provide structural components for cartilage maintenance and exert mild anti-inflammatory effects. The enhanced version, Boneflex Forte, includes a broader array of active ingredients such as marine collagen peptides, Avocado Soybean Unsaponifiables (ASU), Boswellia serrata (standardized to 30% AKBA), curcumin, and ginger root extract. These additional components target multiple inflammatory pathways, including the inhibition of 5-lipoxygenase (5-LOX) and cyclooxygenase (COX) enzymes, as well as the modulation of NF-kappaB signaling. Boneflex is primarily recommended for adults over the age of 40 to maintain joint mobility and reduce pain.

Brand names
BoneflexBoneflex Forte
02

Targets

COXALOX5 (Arachidonate 5-lipoxygenase)NF-κB

Beyond the preview

Go deeper on Boneflex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boneflex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call